Nasdaq Technology

Zacks has many pre-built screens tailored toward common strategies, a list that includes growth, value, momentum, and income.

TXO Partners LP (TXO) concluded the recent trading session at $14.1, signifying a -1.19% move from its prior day's close.

Whirlpool (WHR) closed the most recent trading day at $30.67, moving 2.32% from the previous trading session.

Astrazeneca (AZN) closed at $164.21 in the latest trading session, marking a -1.17% move from the prior day.

Teladoc (TDOC) reached $5.75 at the closing of the latest trading day, reflecting a -2.38% change compared to its last close.

M/I Homes (MHO) concluded the recent trading session at $135.79, signifying a -1.17% move from its prior day's close.

In the most recent trading session, Oneok Inc. (OKE) closed at $86.86, indicating a -1.99% shift from the previous trading day.

In the closing of the recent trading day, Shell (SHEL) stood at $95.14, denoting a -1.38% move from the preceding trading day.

In the closing of the recent trading day, Medpace (MEDP) stood at $622.11, denoting a +1% move from the preceding trading day.

Innovative Industrial Properties (IIPR) closed the most recent trading day at $54.51, moving 1.27% from the previous trading session.

In the closing of the recent trading day, Lyft (LYFT) stood at $15.07, denoting a +1.28% move from the preceding trading day.

Main Street Capital (MAIN) reached $55.94 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.

Garmin (GRMN) concluded the recent trading session at $290.23, signifying a -1.3% move from its prior day's close.

Dow Inc. (DOW) reached $27.61 at the closing of the latest trading day, reflecting a -1% change compared to its last close.

In the closing of the recent trading day, Gladstone Commercial (GOOD) stood at $12.62, denoting a +1.2% move from the preceding trading day.

In the closing of the recent trading day, Ouster, Inc. (OUST) stood at $40, denoting a -2.2% move from the preceding trading day.

Concentrix (CNXC) delivered earnings and revenue surprises of +7.75% and -0.98%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?

Visa, Intuitive Surgical and Williams Companies headline today's research, with growth opportunities balanced by margin, valuation and execution risks.

ESP's fiscal fourth-quarter earnings per share improve year over year, while a solid funded backlog supports revenue visibility. Management expects fiscal 2027 revenues to outpace fiscal 2026.

Discover why Zacks initiated coverage of CNTM with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Learn how revenue growth, cost discipline and strategic expansion are balanced by liquidity constraints and margin pressure.